These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 16153171

  • 1. The genetics of the persistent infection and demyelinating disease caused by Theiler's virus.
    Brahic M, Bureau JF, Michiels T.
    Annu Rev Microbiol; 2005; 59():279-98. PubMed ID: 16153171
    [Abstract] [Full Text] [Related]

  • 2. Theiler's murine encephalomyelitis virus (TMEV): the role of a small out-of-frame protein in viral persistence and demyelination.
    Obuchi M, Ohara Y.
    Jpn J Infect Dis; 1999 Dec; 52(6):228-33. PubMed ID: 10738359
    [Abstract] [Full Text] [Related]

  • 3. [Infection of the mouse by Theiler's virus; a model for the study of demyelinating diseases of the central nervous system].
    Brahic M.
    Bull Acad Natl Med; 1996 Feb; 180(2):305-15; discussion 315-6. PubMed ID: 8705377
    [Abstract] [Full Text] [Related]

  • 4. Genetics of susceptibility to Theiler's virus infection.
    Brahic M, Bureau JF.
    Bioessays; 1998 Aug; 20(8):627-33. PubMed ID: 9780837
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Mouse models of multiple sclerosis: experimental autoimmune encephalomyelitis and Theiler's virus-induced demyelinating disease.
    Fuller KG, Olson JK, Howard LM, Croxford JL, Miller SD.
    Methods Mol Med; 2004 Aug; 102():339-61. PubMed ID: 15286394
    [Abstract] [Full Text] [Related]

  • 8. Analysis of the leader and capsid coding regions of persistent and neurovirulent strains of Theiler's virus.
    Michiels T, Jarousse N, Brahic M.
    Virology; 1995 Dec 20; 214(2):550-8. PubMed ID: 8553557
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Pathogenic immunity in Theiler's virus-induced demyelinating disease: a viral model for multiple sclerosis.
    Kim BS, Palma JP, Inoue A, Koh CS.
    Arch Immunol Ther Exp (Warsz); 2000 Dec 20; 48(5):373-9. PubMed ID: 11140464
    [Abstract] [Full Text] [Related]

  • 15. Innate immune CD11b+Gr-1+ cells, suppressor cells, affect the immune response during Theiler's virus-induced demyelinating disease.
    Bowen JL, Olson JK.
    J Immunol; 2009 Dec 01; 183(11):6971-80. PubMed ID: 19890055
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Adaptation of Theiler's virus to L929 cells: mutations in the putative receptor binding site on the capsid map to neutralization sites and modulate viral persistence.
    Jnaoui K, Michiels T.
    Virology; 1998 May 10; 244(2):397-404. PubMed ID: 9601508
    [Abstract] [Full Text] [Related]

  • 19. Influence of the Theiler's virus L* protein on macrophage infection, viral persistence, and neurovirulence.
    van Eyll O, Michiels T.
    J Virol; 2000 Oct 10; 74(19):9071-7. PubMed ID: 10982352
    [Abstract] [Full Text] [Related]

  • 20. [Theiler's virus encephalomyelitis infection as a model for multiple sclerosis: cytokines and pathogenic mechanisms].
    Molina-Holgado E, Areválo-Martín A, Vela JM, Guaza C.
    Rev Neurol; 2000 Oct 10; 35(10):973-8. PubMed ID: 12436402
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.